Anti-viral drugs for the treatment of H1N1 Influenza which has killed four students of the Kumasi Academy Senior High School(KUMACA) are expected in the country today.

The World Health Organization(WHO) is supplying the anti-viral agents (Tamiflu) following a request from government as it struggles to deal with the situation at KUMACA.

Some students and staff of the Kumasi Academy, the epicentre of the dreaded H1N1 Influenza outbreak have already been vaccinated.

Parents who withdrew their wards from the Kumasi Academy following the outbreak of the deadly atypical bacterial infection disease were also vaccinated.

It was feared that the parents were at risk of contracting the disease after coming into contact with their wards.

Four students of KUMACA died within a week a fortnight ago after they fell ill to a “strange” disease which was later found to be H1N1 Influnza while over 40 others were admitted at the Komfo Anokye Teaching Hospital and the Kwame Nkrumah University of Science and Technology (KNUST) Hospital.

Earlier, 7 other students had died between April and November, after suffering similar ailment which was subsequently established to be Meningitis.